BSE:RESONANCE   RESONANCE SPECIALTIES LTD.
Resonance is engaged in the business of manufacturing and marketing of Pyridine, Picolines, Cynopyridines, Drug Intermediates and APIs.The acquisition of Resonance will help the Company to venture into the field of specialty chemicals, Drug Intermediates and APIs.

Pyridine and Pyridine Derivative has a huge mkt and usage in Covid, According to a report, Global Pyridine and Pyridine Derivatives Market to Reach $822.9 Million by 2027

Amid the COVID-19 crisis, the global market for Pyridine and Pyridine Derivatives estimated at US$567.6 Million in the year 2020, is projected to reach a revised size of US$822.9 Million by 2027, growing at a CAGR of 5.5% over the analysis period 2020-2027.

Pyridine, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$358.9 Million by the end of the analysis period.

Increase in demand for pyridine and its derivatives, especially from agrochemicals and pharmaceutical industries due to their multiple chemical functionalities is driving factor of the global pyridine market.

The Pyridine and Pyridine Derivatives market in the U. S. is estimated at US$153.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$173 Million by the year 2027 trailing a CAGR of 8.4% over the analysis period 2020 to 2027.

The chemicals segment would witness the fastest CAGR of 5.7% through 2025. This is because pyridine is an important raw material in the chemical industry and is used as a solvent, reagent, and precursor for several chemicals. However, the agrochemicals segment held the largest share in 2017, capturing over one-third of the market share and would maintain its lion’s share through 2025. This growth is attributed to the crucial role played by pyridine in the production of fungicides, insecticides/acaricides and herbicides and many more. The report also offers an in-depth analysis of various applications such as pharmaceuticals, food, among others.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

The global Vitamin B3 market is estimated to be valued USD 330 million in 2020 and is expected to reach a value of USD 373 million by 2025, growing at a CAGR of 2.5% during the forecast period. Pyridine and Pyridine Derivatives are used to manufacture Vitamin B3. Vitamin B3 is also used in dairy and Pork Industry for better quality of milk and pork.

Asia-Pacific market for Vitamin B3 is projected to grow at the highest CAGR during the forecast period. Growing incidences of chronic diseases, such as cancer, diabetes, high blood pressure, and osteoporosis, has been fueling the market growth for vitamin B3.

The global vitamin B3 market is dominated by key players such as Lonza Group AG (Switzerland),Jubilant Life Sciences Ltd. . (India), Shandong Hongda Biotechnology Co. Ltd. (China), Vertellus (US), Jiangsu Brother Vitamin Co. Ltd. (China), DSM (Netherlands), Vanetta Ltd. (China), Resonance Specialties Ltd. (India), Lasons India (India) and Zhejiang Lanbo Biotechnology (China).

The leading companies in the global pyridine market include Novasyn Organics, Resonance Specialties Ltd. Labex Corporation, LeeChem India Pvt. Ltd., GFS Chemicals Inc., Seidler Chemical Company, Hudson Chemicals, Prochem Inc., Innova Chemicals and Scientific Solutions, LLC., and others.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.